About
Dr. Balaji Natarajan is an Interventional Cardiologist practicing in Arizona’s West Valley and currently serves as a Consultant with Cardiac Solutions. He cares for patients with a broad range of cardiovascular conditions, including coronary artery disease, heart failure, heart rhythm disorders, hypertension, vascular disease, and preventive heart health. His practice includes minimally invasive and catheter-based procedures, with a focus on delivering thoughtful, individualized cardiovascular care.
Originally from India, Dr. Natarajan earned his medical degree from Amrita School of Medicine before moving to the United States for advanced training and research. He completed residency at the University of Arizona College of Medicine and went on to complete fellowship training in Cardiovascular Disease and Interventional Cardiology at University of California Riverside, where he also served as Chief Cardiology Fellow.
In addition to clinical practice, Dr. Natarajan has remained actively involved in cardiovascular research through work at the National Institutes of Health and collaborations across multiple institutions. He has authored numerous scientific publications and maintains a strong interest in education, innovation, and advances in cardiovascular care.
This blog was created to provide clear, reliable cardiovascular information and help patients better understand heart health and developments in cardiology.
Outside of medicine, Dr. Natarajan enjoys spending time with family, traveling, cooking, and sports.
If you would like to schedule a one-on-one consultation, appointments with Dr. Natarajan can be arranged through Cardiac Solutions at 623-876-8816.
“Delivering expert cardiovascular care with a focus on education, prevention, and innovation.”
Specialty
CardiologyAreas of Focus
Articles by Dr. Balaji Natarajan
Statins: The Truth About Side Effects and Common Myths
A cardiologist's guide to statins: the side effects that are genuinely real (and how common they are), plus 11 common myths separated from the evidence on muscle pain, liver, memory, diabetes, and more.
Coronary Calcium Score: What It Means and Why It Matters
A clear, patient-friendly guide to the coronary artery calcium (CAC) score: what it measures, what the numbers mean, who should consider the test, and how it guides heart-disease prevention under the 2026 ACC/AHA dyslipidemia guideline.
Research & Publications
Dr. Balaji Natarajan has authored and co-authored numerous peer-reviewed scientific publications and presented research at national and international conferences. His academic work spans interventional cardiology, cardiovascular imaging, coronary artery disease, vascular inflammation, heart rhythm disorders, pulmonary vascular disease, and preventive cardiology.
His research career has included collaborations with the National Institutes of Health and multiple academic cardiovascular centers, contributing to advances in cardiovascular care and improving patient outcomes.
Selected Publications
Coronary & Interventional Cardiology
- Myocardial Infarction with Non-Obstructive Coronary Artery Disease (MINOCA): Definition, Diagnosis and Management
- Pathophysiology, Diagnosis and Management of Coronary No-Reflow Phenomenon
- Acute Lower Limb Ischemia: Etiology, Pathology and Management
- Acute Coronary Syndromes and Percutaneous Revascularization
- Outcomes in aVR ST elevation myocardial infarction
Heart Rhythm Disorders
- Is Catheter Ablation Better Than Antiarrhythmic Drugs for Treatment of Atrial Fibrillation?
- Etiology, Pathology and Classification of Atrial Fibrillation
Cardiovascular Imaging
- Comprehensive Pulmonary Valve Imaging by Transesophageal Echocardiography
- Role of Cardiac MRI in Screening Cardiac Sarcoidosis
- Quantifying aortic vascular inflammation using FDG-PET CT/MRI in Psoriasis
Preventive Cardiology & Vascular Inflammation
- Coronary Artery Calcium Scores in Psoriasis and Type 2 Diabetes
- Chronic Stress and Subclinical Cardiovascular Disease
- GlycA as a Novel Biomarker of Cardiovascular Risk
- Aortic Vascular Inflammation and Neutrophil Activation
- Association between skin and aortic vascular inflammation in Psoriasis
- Association between visceral adiposity and Aortic Vascular inflammation
- Neutrophil subsets, vascular inflammation and risk for coronary atherosclerosis in Lupus
Heart Failure
- Management of patients with Heart Failure with preserved EF
Pulmonary Vascular Hypertension
- Genetic admixture and survival in Diverse Populations with Pulmonary HTN
- Diabetes Mellitus and RV/vascular remodeling in PAH
Lipid Biology
- Atherogenic Lipoprotein composition and abnormal function in Psoriasis
- Cholesterol efflux capacity and non-calcified coronary plaque in Psoriasis
Innovations in CV Training
- Role of simulation training in Interventional Cardiology